Procyon Corporation (PCYN)

OTCMKTS · Delayed Price · Currency is USD

0.1800

-0.0050 (-2.70%)

At close: Oct 27, 2026

Market Cap	1.48M +49.8%
Revenue (ttm)	4.98M +6.4%
Net Income	-312.96K
EPS	-0.04
Shares Out	8.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,500
Open	0.1800
Previous Close	0.1850
Day's Range	0.1800 - 0.1800
52-Week Range	0.1200 - 0.2800
Beta	65,152.70
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Procyon

Procyon Corporation, together with its subsidiaries, engages in manufacturing and marketing of wound and skin care products in the United States. The company offers skin and wound care products made with antimicrobial agent under the AMERIGEL hydrogel wound dressing, AMERIGEL post-op surgical kit, AMERIGEL saline wound wash, AMERIGEL care lotion, and AMERIGEL barrier lotion names, as well as EXTREMIT-EASE name. It also provides HELIX3-CP Collagen Powder and HELIX3-CM Collagen Matrix; AMERX wound care kits, AMERX calcium alginate dressings, AMER... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1987

Employees 20

Stock Exchange OTCMKTS

Ticker Symbol PCYN

Full Company Profile

Financial Performance

In fiscal year 2024, Procyon's revenue was $4.98 million, an increase of 6.35% compared to the previous year's $4.69 million. Losses were -$312,962, 367.4% more than in 2023.

Financial Statements